WebThe HighLife Mitral Valve is designed in order to respect the patient’s anatomy. Its outer surface features atraumatic rounded edges with smooth symmetrical structures, as the … HighLife is a company focused on Transcatheter Mitral Valve Replacement … Mitral regurgitation (MR) refers to the lack of competence of the mitral valve (one of … The HighLife Mitral Valve is designed in order to respect the patient’s anatomy. … Click below for additional information: Physician Feedback Publications News - Home - HIGHLIFE MEDICAL FRANCE (Headquarters) HighLife SAS 100 avenue de Suffren 75015 Paris FRANCE: … Georg Börtlein is the founder of HighLife and currently its President and CEO. … Dr. Nicolo Piazza at PCR London Valves 2024: Watch this session presented by … Click on the links below to download HighLife publications: TCT 2024 Poster – … Collaboration Strengthens Peijia’s Position for Competing in a Largely Untapped … WebDec 30, 2024 · HighLife technology offers unique features for treating mitral valve insufficiency. Transcatheter Mitral Valve Replacement ("TMVR") has been trending in the field of interventional therapy of structural heart disease. Early exploratory studies have proved the safety and efficacy of this technology.
HighFLO Study - HighLife Trans-septal Mitral Valve Replacement …
http://www.highlifemedical.com/ Web同时,国内沛嘉HighLife经导管二尖瓣置换(经房间隔二尖瓣置换,TSMVR)系统的多中心注册临床试验已正式启动,将进一步评估该系统治疗中度至重度或重度二尖瓣反流患者的安全性及有效性。 how can you manage stress explain
HighFLO Study - HighLife Trans-septal Mitral Valve
WebJan 12, 2024 · 沛嘉医疗科技(苏州)有限公司,经导管二尖瓣置换系统(High Life TSMVR): High Life TSMVR 是经股静脉房间隔穿刺入路的二尖瓣置换系统。是涌过经主动脉路径在二尖瓣腱索周围预置一个环形结构作为锚定物,植入自膨式牛心包瓣膜,实现二尖瓣 … WebDec 30, 2024 · The implantation of Peijia's Highlife TSMVR system was performed by Professor Mao Chen and his team of West China Medical Center of Sichuan University as part of a research clinical trial. The ... WebAtlanta (Sept. 30, 2024) – Clinicians at Piedmont Heart Institute at Piedmont Atlanta Hospital performed the first HighLife Trans-septal Mitral Valve Replacement (TSMVR) in the United States on July 13, 2024, as part of an early feasibility trial.. This innovative technique is used to treat patients with mitral valve insufficiency or regurgitation using a minimally … how many people use swappa